Literature DB >> 5259761

Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures.

P Gerper, J Whang-Peng, J H Monroe.   

Abstract

Three separate attempts to establish long-term leukocyte cultures from the peripheral blood of a healthy adult who had no evidence of previous infection with Epstein-Barr virus were consistently unsuccessful. On the other hand, in vitro infection of buffy-coat cells of this donor with Epstein-Barr virus resulted in blastoid transformation of the lymphocytes and long-term growth potential. The transformation was accompanied by major chromosome changes. The significance of these findings in relation to lymphoproliferative diseases in man remains to be determined.

Entities:  

Mesh:

Year:  1969        PMID: 5259761      PMCID: PMC223514          DOI: 10.1073/pnas.63.3.740

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures.

Authors:  Y Hinuma; J T Grace
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

2.  Studies on leukocytes growing in continuous culture derived from normal human donors.

Authors:  P Gerber; J H Monroe
Journal:  J Natl Cancer Inst       Date:  1968-04       Impact factor: 13.506

3.  Culture of normal human leukocytes.

Authors:  G E Moore; R E Gerner; H A Franklin
Journal:  JAMA       Date:  1967-02-20       Impact factor: 56.272

4.  C-group chromosome marker in long-term leukocyte cultures.

Authors:  G Kohn; V Diehl; W J Mellman; W Henle; G Henle
Journal:  J Natl Cancer Inst       Date:  1968-09       Impact factor: 13.506

5.  Morphologic variations in human leukemic lymphoblasts (CCRF-CEM cells) after long-term culture and exposure to chemotherapeutic agents. A study with the electron microscope.

Authors:  B G Uzman; G E Foley; S Farber; H Lazarus
Journal:  Cancer       Date:  1966-11       Impact factor: 6.860

6.  Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child.

Authors:  A S Rabson; G T O'Conor; S Baron; J J Whang; F Y Legallais
Journal:  Int J Cancer       Date:  1966-01       Impact factor: 7.396

7.  Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure.

Authors:  J H Pope; B G Achong; M A Epstein; J Biddulph
Journal:  J Natl Cancer Inst       Date:  1967-11       Impact factor: 13.506

8.  Involvement of C group chromosomes in five Burkitt lymphoma cell lines.

Authors:  G Kohn; W J Mellman; P S Moorhead; J Loftus; G Henle
Journal:  J Natl Cancer Inst       Date:  1967-02       Impact factor: 13.506

9.  Establishment of cell lines from peripheral leucocytes in infectious mononucleosis.

Authors:  J H Pope
Journal:  Nature       Date:  1967-11-25       Impact factor: 49.962

10.  Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors:  W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal:  Science       Date:  1967-09-01       Impact factor: 47.728

View more
  52 in total

1.  Infection of human and rhesus lymphoblastoid cells with Herpesvirus macaca.

Authors:  P R Graze; I Royston
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs.

Authors:  H Delius; G W Bornkamm
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

3.  DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus.

Authors:  N Raab-Traub; R Pritchett; E Kieff
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

4.  DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.

Authors:  D Given; E Kieff
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

5.  Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection.

Authors:  A L Powell; W King; E Kieff
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium.

Authors:  J E Shaw; R G Petit; K Leung
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus.

Authors:  M Dolyniuk; R Pritchett; E Kieff
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

8.  Epstein-Barr virus-specific RNA. I. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid cell lines.

Authors:  S D Hayward; E D Kieff
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

Review 9.  Oncogenic properties of human viruses.

Authors:  R Glaser; B Decker; F Rapp
Journal:  In Vitro       Date:  1975 May-Jun

10.  Chemical mutagenesis at the phosphoribosyltransferase locus in cultured human lymphoblasts.

Authors:  K Sato; R S Slesinski; J W Littlefield
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.